• Users Online: 163
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Referee Resource Subscribe
Year : 2014  |  Volume : 1  |  Issue : 1  |  Page : 16-18

Fertility preservation for ovarian or uterine cancer patients with reference to assisted reproduction technology

Head and Chief Embryologist, Thomson Fertility Centre, Singapore

Correspondence Address:
Dr. Ethiraj Balaji Prasath
Thomson Fertility Centre, Novena Specialist Center, # 07-02, 8, Sinaran Drive 307470
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2394-4285.146701

Rights and Permissions

Fertility preservation has been paid much attention recently, as the survival rate of cancer patients after therapy has increased significantly. Cryopreservation of gametes or embryos has been practiced prior to cancer therapy, to preserve fertility, as various modes of cancer therapy are gonadotoxic, reducing reproductive potential of cancer survivors. Although cryopreserving semen or testicular tissue has been the prominent means of fertility preservation for men, it has been still experimental for pre-pubertal boys. Treating by Assisted reproduction Techniques with cryopreservation of oocytes or embryos is the promising way of fertility preservation in women prior to cancer therapy. Livebirths have been reported after auto transplantation of cryopreserved ovarian cortex. Such an approach may not be practical in women with ovarian or endometrial or Estrogen sensitive breast cancer as transplantation of ovarian cortex may reintroduce the disease. Oophorectomy in such patients is not uncommon leading to total infertility of patients. Alternative approaches are available to preserve fertility of such women. Harvesting oocytes for cryopreservation in women without male partners or embryos after in vitro maturation and ICSI of harvested oocytes in women with male partners have been reported as modern means of fertility preservation in ovarian cancer patients. Efficacy of such approaches is reviewed in this article.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded546    
    Comments [Add]    

Recommend this journal